LONG-TERM FUNCTIONAL ISLET MASS AND METABOLIC FUNCTION AFTER XENOISLET TRANSPLANTATION IN PRIMATES 1,2
TRANSPLANTATION OF HIGHLY DIFFERENTIATED IMMORTALIZED HUMAN HEPATOCYTES TO TREAT ACUTE LIVER FAILURE 1
IG-THERASORB IMMUNOAPHERESIS IN ORTHOTOPIC XENOTRANSPLANTATION OF BABOONS WITH LANDRACE PIG HEARTS 1,2
HEPATOCYTE GROWTH FACTOR IS ESSENTIAL FOR AMELIORATION OF HYPERGLYCEMIA IN STREPTOZOTOCIN-INDUCED DIABETIC MICE RECEIVING A MARGINAL MASS OF INTRAHEPATIC ISLET GRAFTS 1,2
MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I PEPTIDE-PULSED HOST DENDRITIC CELLS INDUCE ANTIGEN-SPECIFIC ACQUIRED THYMIC TOLERANCE TO ISLET CELLS 1,2
NOX 100, A NITRIC OXIDE SCAVENGER, ENHANCES CARDIAC ALLOGRAFT SURVIVAL AND PROMOTES LONG-TERM GRAFT ACCEPTANCE 1
EFFECT OF SURROGATE TOLEROGENESIS ON THE VASCULAR REJECTION OF PIG HEART XENOGRAFTS 1,2
PROLONGATION OF CANINE LIVER ALLOGRAFT SURVIVAL BY A NOVEL IMMUNOSUPPRESSANT, FTY720
BILE ACIDS IN XENOGENEIC EX-VIVO LIVER PERFUSION
THE INFLUENCE OF PULSATILE PRESERVATION ON RENAL TRANSPLANTATION IN THE 1990s 1
RIGHT LOBE GRAFT IN LIVING DONOR LIVER TRANSPLANTATION 1,2
RESULTS OF PANCREAS TRANSPLANTATION AFTER STEROID WITHDRAWAL UNDER TACROLIMUS IMMUNOSUPPRESSION 1
LIVER ALLOTRANSPLANTATION AFTER EXTRACORPOREAL HEPATIC SUPPORT WITH TRANSGENIC (hCD55/hCD59) PORCINE LIVERS
OUTCOME IN RECIPIENTS OF DUAL KIDNEY TRANSPLANTS
THE KINETICS OF TOLERANCE INDUCTION BY NONDEPLETING ANTI-CD4 MONOCLONAL ANTIBODY (RIB 5/2) PLUS INTRAVENOUS DONOR ALLOANTIGEN ADMINISTRATION 1,2
BRIEF CYCLOSPORINE TREATMENT PREVENTS INTRATHYMIC (IT) TOLERANCE INDUCTION AND PRECIPITATES ACUTE REJECTION IN AN IT RAT CARDIAC ALLOGRAFT MODEL 1,2
BOTH ISCHEMIC AND PHARMACOLOGICAL PRECONDITIONING DECREASE HEPATIC LEUKOCYTE/ENDOTHELIAL CELL INTERACTIONS 1
DEFINING HEPATOCELLULAR CHIMERISM IN A LIVER FAILURE PATIENT BRIDGED WITH HEPATOCYTE INFUSION 1
EXPERIENCE WITH DACLIZUMAB IN LIVER TRANSPLANTATION
CADAVERIC VERSUS LIVING DONOR KIDNEY TRANSPLANTATION
Announcements